Noble Roman's, Inc.
NROM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5.4% | -0.5% | 4.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 30.7% | 38.5% | 21.1% | 31.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 13% | 24.9% | 9.5% | 22.1% |
| Net Income | -$0 | $0 | -$0 | $0 |
| % Margin | -0% | 10.2% | -7.3% | 3.7% |
| EPS Diluted | -0 | 0.064 | -0.048 | 0.02 |
| % Growth | -100.2% | 235.4% | -337.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |